Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shanghai Menon Animal Nutrition Technology Co., Ltd. (301156.SZ)
Shanghai, CN
Shanghai Menon Animal Nutrition Technology Co., Ltd. specializes in the development, manufacturing, and distribution of animal feed supplements and essential raw materials. Based in China, the company offers a comprehensive range of products, including palatability enhancers, sweetening agents, acidifiers, botanical extracts, sodium butyrate, glyceryl butyrate, emulsifying agents, and various small peptides. These offerings are specifically formulated to support the nutritional requirements of diverse livestock, such as swine, poultry, ruminants, and aquaculture species. Established in 1997 and headquartered in Shanghai, China, Shanghai Menon also boasts a significant international reach, exporting its solutions globally to countries and regions across Asia, Europe, North and South America, Africa, and Oceania.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -26.94% | -16.88% | -16.51% | -15.43% | -10.05% | -2.38% | -13.37% | +30.20% | -9.87% | -9.87% | -9.87% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Packaged Foods: +4.4%+14.2% ★ Q1'26: +59.3% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%+14.7% ★ Q1'26: +51.6% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%+4.2% Q1'26: -2.6% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+9.7% ★ Q1'26: +9.2% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+9.0% ★ Q1'26: +9.3% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%-2.1% ★ Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×0.00× ★ Q1'26: 0.15× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-25 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 2/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 2/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ji Hong Wang | Director & Deputy GM | — | female |
| Qian Zhou | Financial Director & Accounting Supervisor | — | female |
| Wei Hong | Chairman of the Board & GM | — | male |
| Weiwei Zhang | Deputy GM & Board Secretary | — | female |
| Ying Xiong | Director & Deputy GM | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 301156.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
